Prescription Required.
Sitagliptin is the active ingredient in the medication.It belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Type 2 diabetes mellitus: Sitagliptin is used to improve blood sugar control in adults with type 2 diabetes.
It is typically used in combination with diet and exercise.
Sitahenz 50 Tab (Sitagliptin) works by increasing the levels of incretin hormones, such as glucagon-like peptide-1 (GLP-1), in the body. These hormones help lower blood sugar levels by stimulating insulin release from the pancreas and slowing down the release of glucose from the liver.
Store sitagliptin at room temperature, away from moisture and heat.
The dosage of sitagliptin will vary depending on your individual needs and medical condition.
It is usually taken once daily, with or without food.
Always follow your doctor's instructions carefully.
Common side effects include: headache, upper respiratory tract infection, nasopharyngitis (inflammation of the nose and throat), and diarrhea.
Serious side effects are rare but may include: pancreatitis (inflammation of the pancreas), allergic reactions, and joint pain.
Alcohol consumption may interact with sitagliptin and affect blood sugar control. Consult your doctor about alcohol consumption while taking this medication.
Sitagliptin may cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery until you know how this medication affects you.
Sitagliptin is not recommended for use during pregnancy or breastfeeding. Consult your doctor about the risks and benefits before using this medication.
Sitagliptin is not approved for use in children.
Kidney problems may affect the way sitagliptin is processed by the body. Your doctor may adjust your dosage if you have kidney problems.
Liver problems may affect the way sitagliptin is processed by the body. Your doctor may adjust your dosage if you have liver problems.
https://www.drugs.com/mtm/sitagliptin.html
https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment/drc-20351199
https://www.webmd.com/diabetes/oral-diabetes-medications
